Top 10 Questions to Ask Your Doctor About Your Malignant Mesothelioma Cancer Diagnosis
Malignant Mesothelioma can be confusing and devastating. Pronouncing “Mesothelioma” is a challenge, as is the disease. You are your best...
Top 10 Questions to Ask Your Doctor About Your Malignant Mesothelioma Cancer Diagnosis
RS ONCOLOGY PRESENTS POSTERS AT INTERNATIONAL CONFERENCE
RS Oncology Announces New Preclinical Data Show RSO-021 May Block and/or Reverse the Progression of
RS Oncology Announces Completion of First-in-Human Phase 1 Clinical Trial of RSO-021, a Novel Irreve
RS Oncology presents new drug in early clinical development for Mesothelioma and lung cancer patient
AACR 2023, RSO-021, a first in class treatment
Mesothelioma UK
ESMO CONGRESS September 2022
RS Oncology, LLC Announces Initiation of Patient Dosing in Phase 1/2 MITOPE Clinical Trial of RSO-2